Skip to main content
. 2000 Aug;130(7):1678–1684. doi: 10.1038/sj.bjp.0703469

Figure 3.

Figure 3

End-values (mean 110–140 min) for fractional excretion of glucose (FE % glucose) for normoxic and hypoxic perfused kidneys and for hypoxic kidneys treated with tolbutamide or glibenclamide. Data are expressed as mean±s.e.mean (n=4–6), for tolbutamide or glibenclamide treated kidneys versus hypoxia alone (**P<0.01).